You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A Novel Coverglass System with Enhanced Radiation Resistance

    SBC: Infoscitex Corporation            Topic: AF04029

    The Foster-Miller team is developing a novel coverglass system that protects photovoltaic cells on space power systems that are exposed to high doses of ionizing radiation. The spectrum of radiation a solar cell is exposed to not only provides usable energy, over time it also reduces the efficiency of the cell by darkening the barrier coverglass, escalates the operating temperature, and deteriora ...

    SBIR Phase II 2005 Department of DefenseAir Force
  2. Bayesian Troop-Target Detection, Tracking, and Prediction Using FOPEN-GMTI Radar

    SBC: SCIENTIFIC SYSTEMS CO INC            Topic: SB041024

    The "troop-target" problem of automatic detection, tracking, and prediction of the formations of dismounted ground troops concealed in foliage, using FOPEN-GMTI radars introduces challenges well beyond those encountered in more conventional group-target problems. AD HOC troop formations are considerably more amorphous and unpredictable and they must be deduced from the constituent individuals. Y ...

    SBIR Phase II 2005 Department of DefenseDefense Advanced Research Projects Agency
  3. Rapid Clinical Surge-Testing for Biothreat Agents

    SBC: FIRST LIGHT BIOSCIENCES, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Following a bioterrorist attack, hundreds of thousands of potential victims may require testing and treatment. The critical need to test large numbers of people for exposure to a biothreat agent may overwhelm the capacity of the clinical and public health infrastructure. The approximately 25,000 sentinel laboratories in the Laboratory Response Network, which co ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  4. Virtual Bone Biopsy: Transfer to the clinical arena

    SBC: MICROMRI, INC.            Topic: N/A

    Osteoporosis is a major community health problem for which several effective FDA approved therapies exist, but which remains largely undiagnosed and untreated. While bone densitometry using dual-energy x-ray absorptiometry (DXA) is the current "gold standard" in osteoporosis diagnosis, controlled clinical trials have highlighted its sensitivity and specificity limitations at the individual patient ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  5. Low Cost and Rapid DNA-Based Biometric Device

    SBC: NetBio, Inc.            Topic: HSB091001

    Sensitive site exploitation activities are focused on collecting forensic evidence left behind by persons involved in terrorist or other illegal activity, and the biological evidence recovered is often referred to as"touch DNA samples". Touch samples include fingerprints, skin cells found on clothing (e.g. a shirt collar), and oral epithelial cells found on the opening of a soda can or the rim of ...

    SBIR Phase II 2011 Department of DefenseSpecial Operations Command
  6. Development of an anti-malaria toxin vaccine candidate

    SBC: ANCORA PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Malarial disease represents one of the most pressing medical healthcare issues facing the world today. While limited drug treatment options exist, a vaccine solution is widely considered as one of the most effective therapeutic weapons to combat malaria. Despite years of research, though, malarial vaccine initiatives have yet to produce a viable candidate. One ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  7. High Field Magnets for MRI Applications

    SBC: Supercon, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The specific aim of the Phase I and Phase II research program will be to design and build an "open", split pair coil, high field (>1 .5T), cryogen-free MRI magnet. The key innovation that will make this goal feasible is the development of an advanced, high performance, round high temperature superconductor capable of operation at 20 Kelvin. Operating at a te ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  8. Spectral imaging for automated malignant blast counting

    SBC: CAMBRIDGE RESEARCH AND INSTRUMENTATION            Topic: N/A

    DESCRIPTION (provided by applicant): We propose to extend our successful development of an agile spectral light source for light microscopy, funded through the NCI-IMAT initiative, into FDA trials. The SpectraLamp(tm) device enables the automated and quantitative analysis of double-immunostained samples in brightfield (non-fluorescence-based) microscopy, with particular utility for hematopatho ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  9. Low Antigenicity Factor VIII

    SBC: Octagen Corporation            Topic: N/A

    DESCRIPTION (provided by applicant): Octagen's broad, long-term objective is to complete the clinical development and secure FDA approval of its b-domain deleted recombinant factor VIII (OBI-1), a low antigenicity version of factor VIM (fVIII). OBI-1 is designed for the treatment of patients with inhibitory, neutralizing antibodies to human fVIII. Such "inhibitor" patients include congenital hemop ...

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  10. Microfabricated Implantable Flowmeter for CSF Shunts Phase II

    SBC: VIVONICS INC            Topic: NINDS

    DESCRIPTION (provided by applicant): An implantable wireless flow sensor system has been under development that would enable measurement of the flow of cerebrospinal fluid (CSF) through the ventriculoperitoneal (VP) shunt, currently used to treat hydrocephalus patients. CSF flow is a key indicator of shunt function, and there is currently no way to measure it in situ, resulting in the absence ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government